{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T03:41:10Z","timestamp":1791690070495,"version":"4.3.4"},"reference-count":82,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T00:00:00Z","timestamp":1750896000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Thyroid associated ophthalmopathy (TAO) is an autoimmune orbital disease associated with thyroid dysfunction, which may significantly impact the appearance and quality of life of patients. The course of TAO includes active stage and inactive stage, and the treatment methods are different in different stages. The clinical activity score is often used to evaluate the activity of TAO, but it is easy to be affected by subjective factors because it is based on the symptoms and signs of patients. Magnetic resonance imaging (MRI) can evaluate the postorbital tissue structure of TAO more objectively and accurately. A variety of MRI modalities have been used in the diagnosis and treatment of TAO. This article mainly summarizes the application of MRI in diagnosing TAO, assessing its activity, predicting treatment efficacy, and evaluating therapeutic outcomes, thereby providing clinicians with additional evidence-based options.<\/jats:p>","DOI":"10.3389\/fendo.2025.1537957","type":"journal-article","created":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T07:03:33Z","timestamp":1750921413000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["Application progress of magnetic resonance imaging in thyroid associated ophthalmopathy"],"prefix":"10.3389","volume":"16","author":[{"given":"Yan","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing-xing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-yi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-quan","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,6,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra0905750","article-title":"Graves' ophthalmopathy","volume":"362","author":"Bahn","year":"2010","journal-title":"N Engl J Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199311113292007","article-title":"Pathogenesis of graves' ophthalmopathy","volume":"329","author":"Bahn","year":"1993","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1210\/er.2002-0020","article-title":"Current perspective on the pathogenesis of Graves' disease and ophthalmopathy","volume":"24","author":"Prabhakar","year":"2003","journal-title":"Endocr Rev"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.81.9.8784110","article-title":"Evidence of adipocyte differentiation in human orbital fibroblasts in primary culture","volume":"81","author":"Sorisky","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-019-0305-4","article-title":"New insights into the pathogenesis and nonsurgical management of Graves orbitopathy","volume":"16","author":"Taylor","year":"2020","journal-title":"Nat Rev Endocrinol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2015-307399","article-title":"Pathogenesis of thyroid eye disease: review and update on molecular mechanisms","volume":"100","author":"Khong","year":"2016","journal-title":"Br J Ophthalmol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1530\/eje.0.1450107","article-title":"Imaging in thyroid-associated orbitopathy","volume":"145","author":"Kahaly","year":"2001","journal-title":"Eur J Endocrinol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-21-0479","article-title":"The 2021 European Group on Graves' orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves' orbitopathy","volume":"185","author":"Bartalena","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.991588","article-title":"Current insights of applying MRI in Graves' ophthalmopathy","volume":"13","author":"Song","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.K10E-156","article-title":"Orbital magnetic resonance imaging combined with clinical activity score can improve the sensitivity of detection of disease activity and prediction of response to immunosuppressive therapy for Graves' ophthalmopathy","volume":"57","author":"Tachibana","year":"2010","journal-title":"Endocr J"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.28642","article-title":"Application of multiparameter quantitative magnetic resonance imaging in the evaluation of graves' Ophthalmopathy","volume":"58","author":"Li","year":"2023","journal-title":"J Magn Reson Imaging"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(14)72787-4","article-title":"Diagnostic criteria for Graves' ophthalmopathy","volume":"119","author":"Bartley","year":"1995","journal-title":"Am J Ophthalmol"},{"key":"B13","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2011.11.009","article-title":"Neuroimaging of graves' orbitopathy","volume":"26","author":"Muller-Forell","year":"2012","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.2214\/ajr.179.4.1791005","article-title":"Using morphologic parameters of extraocular muscles for diagnosis and follow-up of Graves' ophthalmopathy: diameters, areas, or volumes","volume":"179","author":"Szucs-Farkas","year":"2002","journal-title":"AJR Am J Roentgenol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s10384-015-0410-4","article-title":"Changes of orbital tissue volumes and proptosis in patients with thyroid extraocular muscle swelling after methylprednisolone pulse therapy","volume":"59","author":"Higashiyama","year":"2015","journal-title":"Jpn J Ophthalmol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S105096","article-title":"Relationship between magnetic resonance imaging signal intensity and volume of extraocular muscles in thyroid-associated ophthalmopathy with methylprednisolone pulse therapy","volume":"10","author":"Higashiyama","year":"2016","journal-title":"Clin Ophthalmol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1111\/cen.2018.88.issue-5","article-title":"Establishment of magnetic resonance imaging 3D reconstruction technology of orbital soft tissue and its preliminary application in patients with thyroid-associated ophthalmopathy","volume":"88","author":"Shen","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B18","doi-asserted-by":"publisher","first-page":"759 e11","DOI":"10.1016\/j.crad.2018.02.011","article-title":"Semi-automatic volume measurement for orbital fat and total extraocular muscles based on Cube FSE-flex sequence in patients with thyroid-associated ophthalmopathy","volume":"73","author":"Tang","year":"2018","journal-title":"Clin Radiol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1159\/000510700","article-title":"Proposal for standardization of primary and secondary outcomes in patients with active, moderate-to-severe graves' Orbitopathy","volume":"9","author":"Bartalena","year":"2020","journal-title":"Eur Thyroid J"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0211817","article-title":"Association of anthropometric markers with globe position: A population-based MRI study","volume":"14","author":"Schmidt","year":"2019","journal-title":"PloS One"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-4294","article-title":"Risk factors for graves' Orbitopathy; the Australian thyroid-associated orbitopathy research (ATOR) study","volume":"101","author":"Khong","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1097\/IOP.0000000000001146","article-title":"Dysthyroid optic neuropathy","volume":"34","author":"Saeed","year":"2018","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2006.094607","article-title":"Clinical features of dysthyroid optic neuropathy: a European Group on Graves' Orbitopathy (EUGOGO) survey","volume":"91","author":"McKeag","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1148\/radiology.167.2.3357962","article-title":"Optic nerve dysfunction in thyroid eye disease: CT","volume":"167","author":"Barrett","year":"1988","journal-title":"Radiology"},{"key":"B25","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1159\/000486828","article-title":"Prevalence of radiological signs of dysthyroid optic neuropathy in magnetic resonance imaging in patients with active, moderate-to-severe, and very severe graves orbitopathy","volume":"7","author":"Rutkowska-Hinc","year":"2018","journal-title":"Eur Thyroid J"},{"key":"B26","doi-asserted-by":"publisher","first-page":"e4407","DOI":"10.1002\/nbm.v34.1","article-title":"The feasibility of quantitative MRI of extra-ocular muscles in myasthenia gravis and Graves' orbitopathy","volume":"34","author":"Keene","year":"2021","journal-title":"NMR BioMed"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-021-08030-5","article-title":"The diagnostic value of the IDEAL-T2WI sequence in dysthyroid optic neuropathy: a quantitative analysis of the optic nerve and cerebrospinal fluid in the optic nerve sheath","volume":"31","author":"Wu","year":"2021","journal-title":"Eur Radiol"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-021-08300-2","article-title":"Multiparametric quantitative MRI for the evaluation of dysthyroid optic neuropathy","volume":"32","author":"Zou","year":"2022","journal-title":"Eur Radiol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1259\/bjr\/56958444","article-title":"Use of high-resolution MRI of the optic nerve in Graves' ophthalmopathy","volume":"82","author":"Dodds","year":"2009","journal-title":"Br J Radiol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.851143","article-title":"Multi-parametric diffusion tensor imaging of the optic nerve for detection of dysthyroid optic neuropathy in patients with thyroid-associated ophthalmopathy","volume":"13","author":"Liu","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-023-09829-0","article-title":"Aberrant spontaneous brain activity in patients with thyroid-associated ophthalmopathy with and without optic neuropathy: a resting-state functional MRI study","volume":"33","author":"Liu","year":"2023","journal-title":"Eur Radiol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.eprac.2020.09.006","article-title":"Thyroid-associated ophthalmopathy: preliminary study using T2 mapping to characterize intraorbital optic nerve changes before dysthyroid optic neuropathy","volume":"27","author":"Hu","year":"2021","journal-title":"Endocr Pract"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1080\/02713683.2022.2066697","article-title":"Orbital MRI 3D reconstruction based on volume rendering in evaluating dysthyroid optic neuropathy","volume":"47","author":"Zhang","year":"2022","journal-title":"Curr Eye Res"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-024-10615-9","article-title":"Diagnosis of dysthyroid optic neuropathy: combined value of orbital MRI and intracranial visual pathway diffusion kurtosis imaging","volume":"34","author":"Hu","year":"2024","journal-title":"Eur Radiol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejrad.2005.03.027","article-title":"Signal intensity, clinical activity and cross-sectional areas on MRI scans in thyroid eye disease","volume":"56","author":"Mayer","year":"2005","journal-title":"Eur J Radiol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"19445","DOI":"10.1038\/s41598-020-76341-6","article-title":"Histogram analysis of T2 mapping for detecting early involvement of extraocular muscles in patients with thyroid-associated ophthalmopathy","volume":"10","author":"Liu","year":"2020","journal-title":"Sci Rep"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1038\/eye.1994.126","article-title":"The STIR sequence MRI in the assessment of extraocular muscles in thyroid eye disease","volume":"8","author":"Hoh","year":"1994","journal-title":"Eye (Lond)"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2001.102","article-title":"Serial STIR magnetic resonance imaging correlates with clinical score of activity in thyroid disease","volume":"15","author":"Mayer","year":"2001","journal-title":"Eye (Lond)"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1007\/s00234-009-0590-z","article-title":"Correlation of signal intensity ratio on orbital MRI-TIRM and clinical activity score as a possible predictor of therapy response in Graves' orbitopathy\u2013a pilot study at 1.5 T","volume":"52","author":"Kirsch","year":"2010","journal-title":"Neuroradiology"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1080\/01676830.2017.1423343","article-title":"Novel use of non-echo-planar diffusion weighted MRI in monitoring disease activity and treatment response in active Grave's orbitopathy: An initial observational cohort study","volume":"37","author":"Lingam","year":"2018","journal-title":"Orbit"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2016.3389","article-title":"Diagnosis and stage of Graves' ophthalmopathy: Efficacy of quantitative measurements of the lacrimal gland based on 3-T magnetic resonance imaging","volume":"12","author":"Hu","year":"2016","journal-title":"Exp Ther Med"},{"key":"B42","doi-asserted-by":"publisher","first-page":"16874","DOI":"10.1038\/s41598-017-17257-6","article-title":"Quantitative analysis of inflammation in orbital fat of thyroid-associated ophthalmopathy using MRI signal intensity","volume":"7","author":"Higashiyama","year":"2017","journal-title":"Sci Rep"},{"key":"B43","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1186\/s12902-021-00895-3","article-title":"Quantitative evaluation of activity of thyroid-associated Ophthalmopathy using short-tau inversion recovery (STIR) sequence","volume":"21","author":"Ge","year":"2021","journal-title":"BMC Endocr Disord"},{"key":"B44","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s13244-024-01693-w","article-title":"Dixon MRI-based quantitative parameters of extraocular muscles, intraorbital fat, and lacrimal glands for staging thyroid-associated ophthalmopathy","volume":"15","author":"Pu","year":"2024","journal-title":"Insights Imaging"},{"key":"B45","doi-asserted-by":"publisher","first-page":"20200884","DOI":"10.1259\/bjr.20200884","article-title":"Usefulness of two-point Dixon T2-weighted imaging in thyroid-associated ophthalmopathy: comparison with conventional fat saturation imaging in fat suppression quality and staging performance","volume":"94","author":"Chen","year":"2021","journal-title":"Br J Radiol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.2463\/mrms.tn.2017-0121","article-title":"Quantitative T(2) mapping of knee cartilage: comparison between the synthetic MR imaging and the CPMG sequence","volume":"17","author":"Lee","year":"2018","journal-title":"Magn Reson Med Sci"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1097\/BRS.0b013e318195dd44","article-title":"T2 relaxation times of intervertebral disc tissue correlated with water content and proteoglycan content","volume":"34","author":"Marinelli","year":"2009","journal-title":"Spine (Phila Pa 1976)"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/s41433-018-0304-z","article-title":"T2-relaxation mapping and fat fraction assessment to objectively quantify clinical activity in thyroid eye disease: an initial feasibility study","volume":"33","author":"Das","year":"2019","journal-title":"Eye (Lond)"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1007\/s11596-017-1831-8","article-title":"Three dimensional orbital magnetic resonance T2-mapping in the evaluation of patients with Graves' ophthalmopathy","volume":"37","author":"Hou","year":"2017","journal-title":"J Huazhong Univ Sci Technolog Med Sci"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-022-03167-9","article-title":"The combination of T2-mapping value of lacrimal gland and clinical indicators can improve the stage prediction of Graves' ophthalmopathy compared to clinical activity scores","volume":"78","author":"Jiang","year":"2022","journal-title":"Endocrine"},{"key":"B51","doi-asserted-by":"publisher","first-page":"109815","DOI":"10.1016\/j.ejrad.2021.109815","article-title":"Utility of multi-parametric quantitative magnetic resonance imaging of the lacrimal gland for diagnosing and staging Graves' ophthalmopathy","volume":"141","author":"Wu","year":"2021","journal-title":"Eur J Radiol"},{"key":"B52","doi-asserted-by":"publisher","first-page":"20140677","DOI":"10.1259\/bjr.20140677","article-title":"Graves' ophthalmopathy: the role of diffusion-weighted imaging in detecting involvement of extraocular muscles in early period of disease","volume":"88","author":"Kilicarslan","year":"2015","journal-title":"Br J Radiol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-014-3103-3","article-title":"Magnetic resonance imaging with diffusion-weighted imaging in the evaluation of thyroid-associated orbitopathy: getting below the tip of the iceberg","volume":"24","author":"Politi","year":"2014","journal-title":"Eur Radiol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3348\/kjr.2019.0053","article-title":"Thyroid-associated orbitopathy: evaluating microstructural changes of extraocular muscles and optic nerves using readout-segmented echo-planar imaging-based diffusion tensor imaging","volume":"21","author":"Chen","year":"2020","journal-title":"Korean J Radiol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.eprac.2020.09.008","article-title":"Application of magnetic resonance imaging in the evaluation of disease activity in graves' Ophthalmopathy","volume":"27","author":"Liu","year":"2021","journal-title":"Endocr Pract"},{"key":"B56","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.jcmg.2015.12.001","article-title":"T1-mapping and outcome in nonischemic cardiomyopathy: all-cause mortality and heart failure","volume":"9","author":"Puntmann","year":"2016","journal-title":"JACC Cardiovasc Imaging"},{"key":"B57","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1007\/s00261-019-02382-9","article-title":"T1 mapping, T2 mapping and MR elastography of the liver for detection and staging of liver fibrosis","volume":"45","author":"Hoffman","year":"2020","journal-title":"Abdom Radiol (NY)"},{"key":"B58","doi-asserted-by":"publisher","first-page":"20200685","DOI":"10.1259\/bjr.20200685","article-title":"T1 mapping for the diagnosis of early chronic pancreatitis: correlation with Cambridge classification system","volume":"94","author":"Cheng","year":"2021","journal-title":"Br J Radiol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"2575710","DOI":"10.1155\/2020\/2575710","article-title":"Radiological staging of thyroid-associated ophthalmopathy: comparison of T1 mapping with conventional MRI","volume":"2020","author":"Chen","year":"2020","journal-title":"Int J Endocrinol"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1111\/cen.14178","article-title":"Low signal intensities of MRI T1 mapping predict refractory diplopia in Graves' ophthalmopathy","volume":"92","author":"Matsuzawa","year":"2020","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-021-02873-0","article-title":"Quantitative T1 mapping MRI for the assessment of extraocular muscle fibrosis in thyroid-associated ophthalmopathy","volume":"75","author":"Ma","year":"2022","journal-title":"Endocrine"},{"key":"B62","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1002\/nbm.v14:2","article-title":"Magnetization transfer in MRI: a review","volume":"14","author":"Henkelman","year":"2001","journal-title":"NMR BioMed"},{"key":"B63","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1097\/RLI.0000000000000455","article-title":"Magnetization transfer ratio in peripheral nerve tissue: does it depend on age or location","volume":"53","author":"Kollmer","year":"2018","journal-title":"Invest Radiol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.2214\/AJR.19.21745","article-title":"Fractal analysis of cardiac fibrosis patterns derived from magnetization transfer contrast MRI in patients with end-stage renal disease","volume":"214","author":"Ali","year":"2020","journal-title":"AJR Am J Roentgenol"},{"key":"B65","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1148\/radiol.2017171221","article-title":"Characterization of degree of intestinal fibrosis in patients with crohn disease by using magnetization transfer MR imaging","volume":"287","author":"Li","year":"2018","journal-title":"Radiology"},{"key":"B66","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1097\/RLI.0000000000000711","article-title":"Magnetization transfer imaging predicts porcine kidney recovery after revascularization of renal artery stenosis","volume":"56","author":"Afarideh","year":"2021","journal-title":"Invest Radiol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"110295","DOI":"10.1016\/j.ejrad.2022.110295","article-title":"Multiparametric magnetic resonance imaging for differentiating active from inactive thyroid-associated ophthalmopathy: Added value from magnetization transfer imaging","volume":"151","author":"Hu","year":"2022","journal-title":"Eur J Radiol"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1007\/s00330-020-07540-y","article-title":"Dixon-T2WI magnetic resonance imaging at 3 tesla outperforms conventional imaging for thyroid eye disease","volume":"31","author":"Ollitrault","year":"2021","journal-title":"Eur Radiol"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1089\/thy.1995.5.185","article-title":"MR T2 relaxation time for the assessment of retrobulbar inflammation in Graves' ophthalmopathy","volume":"5","author":"Utech","year":"1995","journal-title":"Thyroid"},{"key":"B70","doi-asserted-by":"crossref","first-page":"2042018820958335","DOI":"10.1177\/2042018820958335","article-title":"Glucocorticoids in Graves' orbitopathy: mechanisms of action and clinical application","volume":"11","author":"Langericht","year":"2020","journal-title":"Ther Adv Endocrinol Metab"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1111\/cts.12999","article-title":"Influence of 4-week or 12-week glucocorticoid treatment on metabolic changes in patients with active moderate-to-severe thyroid-associated ophthalmopathy","volume":"14","author":"Chen","year":"2021","journal-title":"Clin Transl Sci"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1007\/s10384-014-0365-x","article-title":"Use of MRI signal intensity of extraocular muscles to evaluate methylprednisolone pulse therapy in thyroid-associated ophthalmopathy","volume":"59","author":"Higashiyama","year":"2015","journal-title":"Jpn J Ophthalmol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1159\/000348246","article-title":"Differential involvement of orbital fat and extraocular muscles in graves' ophthalmopathy","volume":"2","author":"Wiersinga","year":"2013","journal-title":"Eur Thyroid J"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3348\/kjr.2024.0335","article-title":"Determining disease activity and glucocorticoid response in thyroid-associated ophthalmopathy: preliminary study using dynamic contrast-enhanced MRI","volume":"25","author":"Hu","year":"2024","journal-title":"Korean J Radiol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.29735","article-title":"Quantitative analysis of orbital soft tissues using three-dimensional fast spin echo with 2-point dixon-based fat suppression sequence: its association with methylprednisolone pulse therapy treatment efficacy in thyroid-associated ophthalmopathy","volume":"29","author":"Chen","year":"2025","journal-title":"J Magn Reson Imaging"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2020-317806","article-title":"Teprotumumab reduces extraocular muscle and orbital fat volume in thyroid eye disease","volume":"106","author":"Jain","year":"2022","journal-title":"Br J Ophthalmol"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.1079852","article-title":"Observation study of using a small dose of rituximab treatment for thyroid-associated ophthalmopathy in seven Chinese patients: One pilot study","volume":"13","author":"Wang","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1177\/02841851211034042","article-title":"Evaluation of extraocular muscles in patients with thyroid associated ophthalmopathy using apparent diffusion coefficient measured by magnetic resonance imaging before and after radiation therapy","volume":"63","author":"Yu","year":"2022","journal-title":"Acta Radiol"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.3348\/kjr.2021.0627","article-title":"T2 mapping with and without fat-suppression to predict treatment response to intravenous glucocorticoid therapy for thyroid-associated ophthalmopathy","volume":"23","author":"Zhai","year":"2022","journal-title":"Korean J Radiol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1089\/thy.1992.2.299","article-title":"Role of magnetic resonance imaging in thyroid-associated ophthalmopathy: its predictive value for therapeutic outcome of immunosuppressive therapy","volume":"2","author":"Hiromatsu","year":"1992","journal-title":"Thyroid"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1089\/105072502753600179","article-title":"Role of magnetic resonance imaging in the assessment of disease activity in thyroid-associated ophthalmopathy","volume":"12","author":"Yokoyama","year":"2002","journal-title":"Thyroid"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1002\/jmri.28088","article-title":"T(2) -weighted MR imaging-derived radiomics for pretreatment determination of therapeutic response to glucocorticoid in patients with thyroid-associated ophthalmopathy: comparison with semiquantitative evaluation","volume":"56","author":"Hu","year":"2022","journal-title":"J Magn Reson Imaging"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1537957\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T07:03:33Z","timestamp":1750921413000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1537957\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,26]]},"references-count":82,"alternative-id":["10.3389\/fendo.2025.1537957"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1537957","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,26]]},"article-number":"1537957"}}